Welcure Drugs & Pharmaceuticals (BOM:524661) ROCE % : 3.59% (As of Dec. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Welcure Drugs & Pharmaceuticals ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Welcure Drugs & Pharmaceuticals's annualized ROCE % for the quarter that ended in Dec. 2024 was 3.59%.

Welcure Drugs & Pharmaceuticals ROCE % Historical Data

The historical data trend for Welcure Drugs & Pharmaceuticals's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Welcure Drugs & Pharmaceuticals ROCE % Chart

Welcure Drugs & Pharmaceuticals Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

ROCE %

Get a 7-Day Free Trial

-51.58

131.42

29.06

12.65

-12.24

Welcure Drugs & Pharmaceuticals Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial															-8.02	-5.76	-102.95	7.22	3.59

Welcure Drugs & Pharmaceuticals ROCE % Calculation

Welcure Drugs & Pharmaceuticals's annualized ROCE % for the fiscal year that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	-1.748	/	( ( (15.289 - 0.136)	+	(13.71 - 0.306) )	/ 2 )
	=	-1.748	/	( (15.153	+	13.404)	/ 2 )
	=	-1.748	/	14.2785
	=	-12.24 %

Welcure Drugs & Pharmaceuticals's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	36.548	/	( ( (2698.4 - 1680.06)	+	(0 - 0) )	/ 1 )
	=	36.548	/	( ( 1018.34	+	0 )	/ 1 )
	=	36.548	/	1018.34
	=	3.59 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

Welcure Drugs & Pharmaceuticals (BOM:524661) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Welcure Drugs & Pharmaceuticals ROCE % Related Terms

Thank you for viewing the detailed overview of Welcure Drugs & Pharmaceuticals's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Welcure Drugs & Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Welcure Drugs & Pharmaceuticals Ltd (BOM:524661) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

Laxmi Nagar, Plot No. 55, Office No. 104, First Floor, Vijay Block, Delhi East, Delhi, Delhi, IND, 110092

Website

https://welcuredrugs.com

Welcure Drugs & Pharmaceuticals Ltd is a pharmaceutical company. The company is principally engaged in the manufacturing of pharmaceutical products. The company has one operating segment: Providing services for procurements of order.

Welcure Drugs & Pharmaceuticals Headlines

No Headlines